These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 24750229)

  • 41. Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis.
    Krach F; Wheeler EC; Regensburger M; Boerstler T; Wend H; Vu AQ; Wang R; Reischl S; Boldt K; Batra R; Aigner S; Ravits J; Winkler J; Yeo GW; Winner B
    Acta Neuropathol; 2022 Sep; 144(3):413-435. PubMed ID: 35778567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutation in the RRM2 domain of TDP-43 in Amyotrophic Lateral Sclerosis with rapid progression associated with ubiquitin positive aggregates in cultured motor neurons.
    Maurel C; Madji-Hounoum B; Thepault RA; Marouillat S; Brulard C; Danel-Brunaud V; Camdessanche JP; Blasco H; Corcia P; Andres CR; Vourc'h P
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):149-151. PubMed ID: 28705014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis.
    Freischmidt A; Müller K; Ludolph AC; Weishaupt JH
    Acta Neuropathol Commun; 2013 Jul; 1():42. PubMed ID: 24252274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death.
    Xiao S; Sanelli T; Chiang H; Sun Y; Chakrabartty A; Keith J; Rogaeva E; Zinman L; Robertson J
    Acta Neuropathol; 2015 Jul; 130(1):49-61. PubMed ID: 25788357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dysregulated Expression of Transposable Elements in TDP-43
    Valdebenito-Maturana B; Rojas-Tapia MI; Carrasco M; Tapia JC
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition.
    Torres P; Rico-Rios S; Ceron-Codorniu M; Santacreu-Vilaseca M; Seoane-Miraz D; Jad Y; Ayala V; Mariño G; Beltran M; Miralles MP; Andrés-Benito P; Fernandez-Irigoyen J; Santamaria E; López-Otín C; Soler RM; Povedano M; Ferrer I; Pamplona R; Wood MJA; Varela MA; Portero-Otin M
    Acta Neuropathol; 2024 Sep; 148(1):45. PubMed ID: 39305312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism.
    Keller BA; Volkening K; Droppelmann CA; Ang LC; Rademakers R; Strong MJ
    Acta Neuropathol; 2012 Nov; 124(5):733-47. PubMed ID: 22941224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
    Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
    Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rab1-dependent ER-Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS.
    Soo KY; Halloran M; Sundaramoorthy V; Parakh S; Toth RP; Southam KA; McLean CA; Lock P; King A; Farg MA; Atkin JD
    Acta Neuropathol; 2015 Nov; 130(5):679-97. PubMed ID: 26298469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Loss of hnRNPA1 in ALS spinal cord motor neurons with TDP-43-positive inclusions.
    Honda H; Hamasaki H; Wakamiya T; Koyama S; Suzuki SO; Fujii N; Iwaki T
    Neuropathology; 2015 Feb; 35(1):37-43. PubMed ID: 25338872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.
    Takahashi Y; Uchino A; Shioya A; Sano T; Matsumoto C; Numata-Uematsu Y; Nagano S; Araki T; Murayama S; Saito Y
    Neuropathology; 2019 Aug; 39(4):268-278. PubMed ID: 31124187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions.
    Wu LS; Cheng WC; Shen CK
    J Biomed Sci; 2013 May; 20(1):33. PubMed ID: 23721326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
    Melamed Z; López-Erauskin J; Baughn MW; Zhang O; Drenner K; Sun Y; Freyermuth F; McMahon MA; Beccari MS; Artates JW; Ohkubo T; Rodriguez M; Lin N; Wu D; Bennett CF; Rigo F; Da Cruz S; Ravits J; Lagier-Tourenne C; Cleveland DW
    Nat Neurosci; 2019 Feb; 22(2):180-190. PubMed ID: 30643298
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.
    Mitra J; Guerrero EN; Hegde PM; Liachko NF; Wang H; Vasquez V; Gao J; Pandey A; Taylor JP; Kraemer BC; Wu P; Boldogh I; Garruto RM; Mitra S; Rao KS; Hegde ML
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4696-4705. PubMed ID: 30770445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant.
    Newell K; Paron F; Mompean M; Murrell J; Salis E; Stuani C; Pattee G; Romano M; Laurents D; Ghetti B; Buratti E
    Brain Pathol; 2019 May; 29(3):397-413. PubMed ID: 30461104
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutant TDP-43 Causes Early-Stage Dose-Dependent Motor Neuron Degeneration in a TARDBP Knockin Mouse Model of ALS.
    Ebstein SY; Yagudayeva I; Shneider NA
    Cell Rep; 2019 Jan; 26(2):364-373.e4. PubMed ID: 30625319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress.
    Feneberg E; Gordon D; Thompson AG; Finelli MJ; Dafinca R; Candalija A; Charles PD; Mäger I; Wood MJ; Fischer R; Kessler BM; Gray E; Turner MR; Talbot K
    Neurobiol Dis; 2020 Oct; 144():105050. PubMed ID: 32800996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair.
    Klim JR; Williams LA; Limone F; Guerra San Juan I; Davis-Dusenbery BN; Mordes DA; Burberry A; Steinbaugh MJ; Gamage KK; Kirchner R; Moccia R; Cassel SH; Chen K; Wainger BJ; Woolf CJ; Eggan K
    Nat Neurosci; 2019 Feb; 22(2):167-179. PubMed ID: 30643292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.